⚡ Technology🌐 Global
FDA Advisors Unanimously Back Moderna's mRNA Vaccine After Months of Political Obstruction
Ars Technica·Saturday, 20 June 2026
A panel of FDA advisors has voted unanimously to recommend approval of Moderna's mRNA vaccine, ending a months-long delay. A Trump administration official had refused to even review the vaccine back in February. The unanimous vote is seen as a rebuke of that political interference.
Why It Matters
mRNA vaccine technology is central to future pandemic preparedness globally, and political interference in drug approvals in the world's largest pharma market has ripple effects for health systems everywhere.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.
More from Technology
- Google to Roll Out Android Developer Verification This Month — Big Changes From September
- Apple's Beats Studio Buds Had a Year-Old Eavesdropping Flaw — Finally Fixed
- Microsoft Finds New Malware That Steals Crypto via USB and Hides on Tor
- Chinese Investors Secretly Bought SpaceX Stakes Before Its IPO — One Tied to Military Contractors